Search Results
Search for other papers by Anna H Kongsted in
Google Scholar
PubMed
Search for other papers by Sanne V Husted in
Google Scholar
PubMed
Search for other papers by Malin P Thygesen in
Google Scholar
PubMed
Search for other papers by Vibeke G Christensen in
Google Scholar
PubMed
Search for other papers by Dominique Blache in
Google Scholar
PubMed
Search for other papers by Anders Tolver in
Google Scholar
PubMed
Search for other papers by Torben Larsen in
Google Scholar
PubMed
Search for other papers by Bjørn Quistorff in
Google Scholar
PubMed
Search for other papers by Mette O Nielsen in
Google Scholar
PubMed
Introduction The prevalence of metabolic syndrome and type 2 diabetes (T2D) is increasing in an epidemic-like fashion, and it is particularly pronounced in developing countries currently undergoing rapid economic transition and experiencing
Search for other papers by Ivana Vaněčková in
Google Scholar
PubMed
Search for other papers by Lenka Maletínská in
Google Scholar
PubMed
Search for other papers by Michal Behuliak in
Google Scholar
PubMed
Search for other papers by Veronika Nagelová in
Google Scholar
PubMed
Search for other papers by Josef Zicha in
Google Scholar
PubMed
Search for other papers by Jaroslav Kuneš in
Google Scholar
PubMed
epigenetics to obesity, hypertension, and/or metabolic syndrome is less clear ( Egger et al . 2004 , Gallou-Kabani & Junien 2005 ). We can speculate that obesity-related hypertension develops as a consequence of ‘errors’ in well-coordinated regulatory
Search for other papers by J D Bailey in
Google Scholar
PubMed
Search for other papers by J G Berardinelli in
Google Scholar
PubMed
Search for other papers by T E Rocke in
Google Scholar
PubMed
Search for other papers by R A Bessen in
Google Scholar
PubMed
the stage of infection (i.e., preclinical compared with clinical). Specifically, in the 139H scrapie model, a severe preclinical anabolic syndrome was evident and was more pronounced when hamsters were non-fasted, whereas in the HY TME model a severe
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Iwona J Bujalska in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Omar M Durrani in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Joseph Abbott in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Claire U Onyimba in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Pamela Khosla in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Areeb H Moosavi in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Tristan T Q Reuser in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Paul M Stewart in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Jeremy W Tomlinson in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Elizabeth A Walker in
Google Scholar
PubMed
Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham,
Birmingham and Midland Eye Centre, Dudley Road, Birmingham B18 7QU, UK
Search for other papers by Saaeha Rauz in
Google Scholar
PubMed
), ocular surface renewal ( Onyimba et al. 2006 ), inflammation ( Thieringer et al. 2001 , Zhang et al. 2005 ) and the metabolic syndrome – a cluster of cardiovascular risk factors, including hypertension, obesity, hyperlipidaemia and insulin
Search for other papers by Felipe de Oliveira Franco in
Google Scholar
PubMed
Search for other papers by Magno Alves Lopes in
Google Scholar
PubMed
Search for other papers by Felipe dos Santos Henriques in
Google Scholar
PubMed
Search for other papers by Rodrigo Xavier das Neves in
Google Scholar
PubMed
Search for other papers by Cesário Bianchi Filho in
Google Scholar
PubMed
Cancer Metabolism Research Group, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
Search for other papers by Miguel Luiz Batista Jr in
Google Scholar
PubMed
95 1028 – 1037 . ( doi:10.1038/sj.bjc.6603360 ) Bjorndal B Burri L Staalesen V Skorve J Berge RK 2011 Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic
School of Medicine, Mater Research Institute, The Translational Research Institute, Princess Alexandra Hospital, University of Queensland, Herston, Queensland, Australia
School of Medicine, Mater Research Institute, The Translational Research Institute, Princess Alexandra Hospital, University of Queensland, Herston, Queensland, Australia
Search for other papers by Johanna L Barclay in
Google Scholar
PubMed
School of Medicine, Mater Research Institute, The Translational Research Institute, Princess Alexandra Hospital, University of Queensland, Herston, Queensland, Australia
Search for other papers by Hadiya Agada in
Google Scholar
PubMed
School of Medicine, Mater Research Institute, The Translational Research Institute, Princess Alexandra Hospital, University of Queensland, Herston, Queensland, Australia
Search for other papers by Christina Jang in
Google Scholar
PubMed
School of Medicine, Mater Research Institute, The Translational Research Institute, Princess Alexandra Hospital, University of Queensland, Herston, Queensland, Australia
Search for other papers by Micheal Ward in
Google Scholar
PubMed
Search for other papers by Neil Wetzig in
Google Scholar
PubMed
School of Medicine, Mater Research Institute, The Translational Research Institute, Princess Alexandra Hospital, University of Queensland, Herston, Queensland, Australia
School of Medicine, Mater Research Institute, The Translational Research Institute, Princess Alexandra Hospital, University of Queensland, Herston, Queensland, Australia
Search for other papers by Ken K Y Ho in
Google Scholar
PubMed
activated BAT. These observations provide persuasive evidence for a significant metabolic role of BAT in humans. Glucocorticoids (GCs) play a critical role in the regulation of energy balance. Chronic GC excess, as exemplified in Cushing's syndrome, results
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Susan Kralisch in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Johannes Klein in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Ulrike Lossner in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Matthias Bluher in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Michael Stumvoll in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Mathias Fasshauer in
Google Scholar
PubMed
symptoms of the metabolic syndrome including insulin resistance and obesity ( Masuzaki et al. 2001 ). Furthermore, studies in humans confirm that local overexpression of 11β-HSD-1 in adipocytes might contribute to insulin resistance found in obesity
Search for other papers by Juthamard Surapongchai in
Google Scholar
PubMed
Search for other papers by Mujalin Prasannarong in
Google Scholar
PubMed
Search for other papers by Tepmanas Bupha-Intr in
Google Scholar
PubMed
Search for other papers by Vitoon Saengsirisuwan in
Google Scholar
PubMed
characterized by phenotypic features of non-obese metabolic syndrome, whereas ANGII-500-treated rats exhibited diabetes-like symptoms. Rodents infused with a broad range of ANGII concentrations (10–1440 ng/kg/min) via implantable osmotic minipumps have been
Search for other papers by Laurie Rouger in
Google Scholar
PubMed
Search for other papers by G Raphaël Denis in
Google Scholar
PubMed
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, WELBIO, Université Paris Diderot, Euroscreen SA, Université Libre de Bruxelles, Campus Erasme, Route de Lennik 808, B-1070 Brussels, Belgium
Search for other papers by Souphalone Luangsay in
Google Scholar
PubMed
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, WELBIO, Université Paris Diderot, Euroscreen SA, Université Libre de Bruxelles, Campus Erasme, Route de Lennik 808, B-1070 Brussels, Belgium
Search for other papers by Marc Parmentier in
Google Scholar
PubMed
Introduction Obesity and associated disorders, such as type 2 diabetes, metabolic syndrome, and cardiovascular diseases, constitute a rapidly growing health problem in Western countries. According to the World Health Organization, worldwide obesity
Search for other papers by Keisuke Ishizawa in
Google Scholar
PubMed
Search for other papers by Narantungalag Dorjsuren in
Google Scholar
PubMed
Search for other papers by Yuki Izawa-Ishizawa in
Google Scholar
PubMed
Search for other papers by Rika Sugimoto in
Google Scholar
PubMed
Search for other papers by Yasumasa Ikeda in
Google Scholar
PubMed
Search for other papers by Yoshitaka Kihira in
Google Scholar
PubMed
Search for other papers by Kazuyoshi Kawazoe in
Google Scholar
PubMed
Search for other papers by Shuhei Tomita in
Google Scholar
PubMed
Search for other papers by Koichiro Tsuchiya in
Google Scholar
PubMed
Search for other papers by Kazuo Minakuchi in
Google Scholar
PubMed
Search for other papers by Toshiaki Tamaki in
Google Scholar
PubMed
Introduction Metabolic syndrome (MS) is known to be associated with obesity, type 2 diabetes mellitus, and hypertension, and the coexistence of these diseases leads to cardiovascular disease (CVD; Sowers et al . 2001 , Lorenzo et al . 2003